Skip to main content
SpringerLink
Log in

Reaction of pyridoxamine with malondialdehyde: Mechanism of inhibition of formation of advanced lipoxidation end-products

  • Published:
Amino Acids Aims and scope Submit manuscript

Summary.

Advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs) are implicated in many age-related chronic diseases and in protein aging. Recent studies suggest that pyridoxamine (PM) is an efficient AGEs/ALEs inhibitor in various biological systems. Because malondialdehyde (MDA) is an important intermediate in the formation of ALEs during lipid peroxidation, the purpose of this study is to determine whether PM can trap MDA directly and thereby prevent ALEs formation. PM reacted readily with MDA under physiological conditions. Within 6 h, a 1-pyridoxamino-propenal adduct derived from reaction of equimolar PM + MDA was detected. A 1-amino-3-iminopropene complex and a dihydropyridine-pyridinium complex were also identified after 7 d incubation. PM also greatly inhibited the lipofuscin-like fluorescence formation induced by MDA reaction with bovine serum albumin (BSA). Our results showed clearly that PM inhibited the formation of ALEs by trapping MDA directly under physiological condition, and provide insight into the mechanism of action of PM in protecting proteins against carbonyl stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • NL Alderson ME Chachich NN Youssef RJ Beattie M Nachtigal SR Thorpe JW Baynes (2003) ArticleTitleThe AGEs inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney Int 63 2123–2133 Occurrence Handle1:CAS:528:DC%2BD3sXkvVyiu7o%3D Occurrence Handle12753299 Occurrence Handle10.1046/j.1523-1755.2003.00027.x

    Article  CAS  PubMed  Google Scholar 

  • V Amarnath K Amarnath K Amarnath S Davies LJ Roberts (2004) ArticleTitlePyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls. Chem Res Toxicol 17 410–415 Occurrence Handle1:CAS:528:DC%2BD2cXht1aiu74%3D Occurrence Handle15025512 Occurrence Handle10.1021/tx0300535

    Article  CAS  PubMed  Google Scholar 

  • JW Baynes SR Thorpe (2000) ArticleTitleGlycation and lipoxidation in atherogensis. Free Radic Biol Med 28 1708–1716 Occurrence Handle1:CAS:528:DC%2BD3cXls1Giu7k%3D Occurrence Handle10946212 Occurrence Handle10.1016/S0891-5849(00)00228-8

    Article  CAS  PubMed  Google Scholar 

  • GJ Brealey M Kasha (1955) ArticleTitleThe role of hydrogen bonding in the n → π* blue-shift phenomenon. J Am Chem Soc 77 4462–4468 Occurrence Handle1:CAS:528:DyaG2MXot1ensQ%3D%3D Occurrence Handle10.1021/ja01622a006

    Article  CAS  Google Scholar 

  • M Brownlee (1995) ArticleTitleAdvanced protein glycosylation in diabetes and aging. Annu Rev Med 46 223–234 Occurrence Handle1:CAS:528:DyaK2MXkvFSks7g%3D Occurrence Handle7598459

    CAS  PubMed  Google Scholar 

  • KS Chio AL Tapple (1969) ArticleTitleSynthesis and characterization of the fluorescent products derived from malondialdehyde and amino acids. Biochemistry 8 2821–2832 Occurrence Handle1:CAS:528:DyaF1MXksFSntb4%3D Occurrence Handle5808334

    CAS  PubMed  Google Scholar 

  • CA Colaco CR Harrington (1994) ArticleTitleGlycation: a pathological modification in neuropathies? a hypothesis. Neuroreport 5 859–861 Occurrence Handle1:STN:280:ByuA3sbktlM%3D Occurrence Handle8061282

    CAS  PubMed  Google Scholar 

  • TP Degenhardt NL Alderson DD Arrington RJ Beattie JM Basgen MW Steffes SR Thorpe JW Baynes (2002) ArticleTitlePyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61 939–950 Occurrence Handle1:CAS:528:DC%2BD38Xit1agurY%3D Occurrence Handle11849448 Occurrence Handle10.1046/j.1523-1755.2002.00207.x

    Article  CAS  PubMed  Google Scholar 

  • H Esterbauer RJ Schaur H Zollner (1991) ArticleTitleChemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 11 81–128 Occurrence Handle1:CAS:528:DyaK3MXmsFSnsbo%3D Occurrence Handle1937131 Occurrence Handle10.1016/0891-5849(91)90192-6

    Article  CAS  PubMed  Google Scholar 

  • K Itakura K Uchida (2001) ArticleTitleEvidence that malondialdehyde-derived aminoenimine is not a fluorescent age pigment. Chem Res Toxicol 14 473–475 Occurrence Handle1:CAS:528:DC%2BD3MXjtVCqt7k%3D Occurrence Handle11368543 Occurrence Handle10.1021/tx010055u

    Article  CAS  PubMed  Google Scholar 

  • K Itakura K Uchida T Osawa (1996) ArticleTitleA novel fluorescent malondialdehyde-lysine adduct. Chem Phys Lipids 84 75–79 Occurrence Handle1:CAS:528:DyaK28XmvFartbY%3D

    CAS  Google Scholar 

  • K Kikugawa K Tsukuda T Kurechi (1980) ArticleTitleStudies on peroxidized lipids. 1. Interaction of malondialdehyde with secondary amine and its relevance to nitrosamine formation. Chem Pharm Bull 28 3323–3331 Occurrence Handle1:CAS:528:DyaL3MXhslCiu78%3D

    CAS  Google Scholar 

  • K Kikugawa Y Machida M Kida T Kurechi (1981) ArticleTitleStudies on peroxidized lipids. III. Fluorescent pigments derived from the reaction of malondialdehyde and amino acids. Chem Pharm Bull 29 3003–3011 Occurrence Handle1:CAS:528:DyaL38XosF2nuw%3D%3D

    CAS  Google Scholar 

  • RG Khalifah JW Baynes BG Hudson (1999) ArticleTitleAmadorins: novel post-amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun 257 251–258 Occurrence Handle1:CAS:528:DyaK1MXit1yksr8%3D Occurrence Handle10198198 Occurrence Handle10.1006/bbrc.1999.0371

    Article  CAS  PubMed  Google Scholar 

  • WR Markesberry (1995) ArticleTitleOxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23 134–147

    Google Scholar 

  • TO Metz NL Alderson SR Thorpe JW Baynes (2003) ArticleTitlePyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch Biochem Biophys 419 41–49 Occurrence Handle1:CAS:528:DC%2BD3sXotVCjur0%3D Occurrence Handle14568007 Occurrence Handle10.1016/j.abb.2003.08.021

    Article  CAS  PubMed  Google Scholar 

  • T Miyata K Kurokawa C Van Ypersele De Strihou (2000) ArticleTitleAdvanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11 1744–1752 Occurrence Handle1:CAS:528:DC%2BD3cXntFKru7c%3D Occurrence Handle10966500

    CAS  PubMed  Google Scholar 

  • T Miyata C Van Ypersele de Strihou K Kurokawa JW Baynes (1999) ArticleTitleAlterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int 55 389–399 Occurrence Handle1:CAS:528:DyaK1MXht1Ghtbk%3D Occurrence Handle9987064 Occurrence Handle10.1046/j.1523-1755.1999.00302.x

    Article  CAS  PubMed  Google Scholar 

  • RH Nagaraj P Sarkar A Mally KM Biemel MO Lederer PS Padayatti (2002) ArticleTitleEffect of Pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of PM and methylglyoxal. Arch Biochem Biophys 402 110–119 Occurrence Handle1:CAS:528:DC%2BD38XktlGqs7s%3D Occurrence Handle12051689 Occurrence Handle10.1016/S0003-9861(02)00067-X

    Article  CAS  PubMed  Google Scholar 

  • LJ Niedernhofer JS Daniels CA Rouzer RE Greene LJ Marnett (2003) ArticleTitleMalondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278 31426–31433 Occurrence Handle1:CAS:528:DC%2BD3sXmtFCjs78%3D Occurrence Handle12775726 Occurrence Handle10.1074/jbc.M212549200

    Article  CAS  PubMed  Google Scholar 

  • JM Onorato AJ Jenkins SR Thorpe JW Baynes (2000) ArticleTitlePyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. J Biol Chem 275 21177–21184 Occurrence Handle1:CAS:528:DC%2BD3cXkvFGjur4%3D Occurrence Handle10801874 Occurrence Handle10.1074/jbc.M003263200

    Article  CAS  PubMed  Google Scholar 

  • HK Shapiro (1998) ArticleTitleCarbonyl-trapping therapeutic strategies. Am J Ther 5 323–353 Occurrence Handle1:STN:280:DC%2BD3c%2FptFartA%3D%3D Occurrence Handle10099076

    CAS  PubMed  Google Scholar 

  • DA Slatter M Murray AJ Bailey (1998) ArticleTitleFormation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems. FEBS Lett 421 180–184 Occurrence Handle1:CAS:528:DyaK1cXislyiug%3D%3D Occurrence Handle9468302 Occurrence Handle10.1016/S0014-5793(97)01554-8

    Article  CAS  PubMed  Google Scholar 

  • DA Slatter CH Bolton AJ Bailey (2000) ArticleTitleThe importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 43 550–557 Occurrence Handle1:CAS:528:DC%2BD3cXivV2ksbo%3D Occurrence Handle10855528 Occurrence Handle10.1007/s001250051342

    Article  CAS  PubMed  Google Scholar 

  • A Stitt TA Gardiner NL Anderson P Canning N Frizzell N Duffy C Boyle AS Januszewski M Chachich JW Baynes SR Thorpe (2002) ArticleTitleThe AGEs inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51 2826–2832 Occurrence Handle1:CAS:528:DC%2BD38Xmsleru7o%3D Occurrence Handle12196477

    CAS  PubMed  Google Scholar 

  • SR Thorpe JW Baynes (1996) ArticleTitleRole of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9 69–77 Occurrence Handle1:STN:280:BymH3MfgtVM%3D Occurrence Handle8820792

    CAS  PubMed  Google Scholar 

  • PA Voziyan RG Khalifah C Thibaudeau A Yildiz J Jacob AS Serianni BG Hudson (2003) ArticleTitleModification of proteins in vitro by physiological levels of glucose: Pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J Biol Chem 278 46616–46624 Occurrence Handle1:CAS:528:DC%2BD3sXovFKksr8%3D Occurrence Handle12975371 Occurrence Handle10.1074/jbc.M307155200

    Article  CAS  PubMed  Google Scholar 

  • PA Voziyan TO Metz JW Baynes BG Hudson (2002) ArticleTitleA post-Amadori inhibitor Pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 277 3397–3403 Occurrence Handle1:CAS:528:DC%2BD38XhtVaktrw%3D Occurrence Handle11729198 Occurrence Handle10.1074/jbc.M109935200

    Article  CAS  PubMed  Google Scholar 

  • H Wang LJ Marnett TM Harris CJ Rizzo (2004) ArticleTitleA novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine. Chem Res Toxicol 17 144–149 Occurrence Handle1:CAS:528:DC%2BD2cXitFOntw%3D%3D Occurrence Handle14967001

    CAS  PubMed  Google Scholar 

  • D Yin (1995) ArticleTitleStudies on age pigments evolving into a new theory of biological aging. Gerontology 41 IssueID[Suppl 2] 159–172 Occurrence Handle1:CAS:528:DyaK28XhsFGru7c%3D Occurrence Handle8821329

    CAS  PubMed  Google Scholar 

  • D Yin (1996) ArticleTitleBiochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 21 871–888 Occurrence Handle1:CAS:528:DyaK28XmsFyhu74%3D Occurrence Handle8902532 Occurrence Handle10.1016/0891-5849(96)00175-X

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aging Biochemistry Lab, College of Life Sciences, Hunan Normal University, Changsha, Hunan, Peoples’ Republic of China

    Z. Kang, H. Li, G. Li & D. Yin

Authors
  1. Z. Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, Z., Li, H., Li, G. et al. Reaction of pyridoxamine with malondialdehyde: Mechanism of inhibition of formation of advanced lipoxidation end-products. Amino Acids 30, 55–61 (2006). https://doi.org/10.1007/s00726-005-0209-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-005-0209-6

Search

Navigation